Inventor · disambiguated record
Ulrik Mouritzen
Also filed as: MOURITZEN ULRIK
3 granted patents·5 pending applications·0 citations·filing 2011–2024
44Inventor score
Top patents by PatentIndex Score
8 records- 0168US12297251B1Injection pen for subcutaneous administration of a peptideZEALAND PHARMA AS·Filed 2023·Granted May 13, 2025·0 cites·9 claims
- 0268US2025136657A1Method for adjusting a parenteral support (ps) volume in a human subjectZEALAND PHARMA AS·Filed 2024·Application pending·0 cites
- 0353US2020000883A1Dosage regimes for the administration of glucagon-like-peptide-2 (glp-2) analoguesZEALAND PHARMA AS·Filed 2019·Application pending·0 cites
- 0445US2025049758A1Danegaptide Formulation for Application in the EyeBREYE THERAPEUTICS APS·Filed 2022·Application pending·0 cites
- 0544US2024108598A1Danegaptide for Use in the Treatment or Prevention of a Kidney DiseaseCIANA THERAPEUTICS APS·Filed 2022·Application pending·0 cites
- 0643US2025018002A1Gap Junction Modulators and Their Use for the Treatment of Age-Related Macular DegenerationBREYE THERAPEUTICS APS·Filed 2022·Application pending·0 cites
- 0738US11324799B2Gap junction intercellular communication modulators and their use for the treatment of diabetic eye diseaseZEALAND PHARMA AS·Filed 2018·Granted May 10, 2022·0 cites·12 claims
- 0828US8961950B2Neoadjuvant treatment of cancer with proleukinMOURITZEN ULRIK·Filed 2011·Granted Feb 24, 2015·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Ulrik Mouritzen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →